Literature DB >> 6503518

[Stress tolerance in general thoracic surgery].

I Vogt-Moykopf, G Pierro, W Pertzborn.   

Abstract

The degree of lung tissue-reducing operative procedures is determined by the functional reserves of the patients. The borderline functional reserves are well defined. The 30 days postoperative lethality may be regarded as the criterion for the immediate stress due to the surgery of the bronchial carcinoma. It amounts for pneumonectomies to 6-7% and for lobectomies to 3-4%. An unsolved problem is bifurcation surgery, which still leads to a lethality of 30%. Simultaneous bilateral resection of lung metastases has to prove its efficacy by long term observation employing an interdisciplinary concept. The operation lethality of the mesothelioma has decreased to 12%, long term observations are still missing.

Entities:  

Mesh:

Year:  1984        PMID: 6503518     DOI: 10.1007/bf01823193

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  5 in total

1.  [Surgery of lung metastasis].

Authors:  H Toomes; H G Manke; I Vogt-Moykopf; P Drings
Journal:  Chirurg       Date:  1981-01       Impact factor: 0.955

2.  Modern thirty-day operative mortality for surgical resections in lung cancer.

Authors:  R J Ginsberg; L D Hill; R T Eagan; P Thomas; C F Mountain; J Deslauriers; W A Fry; R O Butz; M Goldberg; P F Waters
Journal:  J Thorac Cardiovasc Surg       Date:  1983-11       Impact factor: 5.209

3.  Sleeve resection of the bronchus and pulmonary artery for pulmonary lesions.

Authors:  I Vogt-Moykopf; H Toomes; S Heinrich
Journal:  Thorac Cardiovasc Surg       Date:  1983-08       Impact factor: 1.827

4.  [Clinical research in lung surgery].

Authors:  I Vogt-Moykopf; H Toomes; H G Manke
Journal:  Chirurg       Date:  1983-04       Impact factor: 0.955

5.  [Parenchyma-preserving resection techniques for bronchial carcinoma (author's transl)].

Authors:  I Vogt-Moykopf; U Abel; S Heinrich; H Toomes; H Wesch
Journal:  Langenbecks Arch Chir       Date:  1981
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.